January 2022 DAIT Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.

NB: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

Fiscal Year (FY) 2023 Concepts

FY 2023 Small Business Innovation Research (SBIR) Contract Solicitation Topics

NIAID Vaccine Adjuvant Development Program in Infectious and Immune-Mediated Diseases

For the published broad agency announcement, check the April 13, 2022, solicitation NIAID Vaccine Adjuvant Development Program in Infectious and Immune-Mediated Diseases.

Notice of Special Interest (NOSI)—Optimizing Vascularized Composite Allograft Survival

For the published notice of special interest, check the February 23, 2022 Guide notice, Notice of Special Interest (NOSI)—Optimizing Vascularized Composite Allograft Survival.

Adjuvant Development for Vaccines for Infectious and Immune-Mediated Diseases

Note: NIAID topic proposed for NIH SBIR contract solicitation PHS 2023-1.

Request for Proposals

Contact
Charles H. Jackson, Jr.
charles.jackson@nih.gov

Adjuvant Discovery for Vaccines for Infectious and Immune-Mediated Diseases

Note: NIAID topic proposed for NIH SBIR contract solicitation PHS 2023-1.

Request for Proposals

Contact
Charles H. Jackson, Jr.
charles.jackson@nih.gov

Reagents for Immunologic Analysis of Non-Mammalian and Underrepresented Mammalian Models

Note: NIAID topic proposed for NIH SBIR contract solicitation PHS 2023-1.

Request for Proposals

Contact
Charles H. Jackson, Jr.
charles.jackson@nih.gov

Content last reviewed on